Confluent director Matthew Miller sells $17m in inventory

3 months ago

Matthew Craig Miller, a director at Confluent , Inc. (NASDAQ:CFLT), lately executed a collection of inventory transactions ensuing within the…

YCBD Inventory Touches 52-Week Low at $0.41 Amid Market Challenges

3 months ago

In a difficult market setting, shares of cbdMD, Inc. (NYSE:YCBD) have reached a 52-week low, dipping to $0.41. With a…

Avanos Medical’s SWOT evaluation: healthcare agency’s inventory faces transformation hurdles

3 months ago

Avanos Medical , Inc. (NYSE:AVNS), a healthcare firm specializing in medical units and tools with a market capitalization of $809…

Adani Ports withdraws DFC funding request for Colombo port mission

3 months ago

(Reuters) -India's Adani Ports and Particular Financial Zone Ltd stated on Tuesday it might finance its Colombo port terminal mission…

Gold costs dip from over 2-wk excessive; Copper good points on China stimulus cheer

3 months ago

Investing.com-- Gold costs fell from a more-than two-week excessive in Asian commerce on Thursday as buyers gauged the implications of…

Asia FX positive factors on elevated US charge reduce bets, China stimulus in focus

3 months ago

Investing.com-- Most Asian currencies inched greater on Thursday as U.S. inflation knowledge cemented bets for a Federal Reserve rate of…

Wall Road largely upbeat on GM’s choice to tug the plug on Cruise

3 months ago

By Nora Eckert and David Shepardson DETROIT (Reuters) -Basic Motors wanted to exit its Cruise robotaxi enterprise, most Wall Road…

Rockwell Automation SVP sells shares value over $79,000

3 months ago

Veena M. Lakkundi, Senior Vice President of Technique and Company Improvement at Rockwell Automation, Inc. (NYSE:ROK), just lately executed a…

SST inventory touches 52-week low at $0.91 amid market challenges

3 months ago

In a difficult market setting, SST inventory has reached a 52-week low, buying and selling at $0.91, with InvestingPro evaluation…

Arvinas’s SWOT evaluation: protein degrader’s inventory faces pivotal trial

3 months ago

Arvinas Inc. (NASDAQ:ARVN), a biopharmaceutical firm specializing in protein degradation therapeutics, stands at a essential juncture because it approaches key…